Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade. Issue 12 (27th December 2022)

• Record Type: Journal Article
• Authors: Uchida, Tsuyoshi; Matsubara, Hirochika; Muto, Mamoru; Sasanuma, Harunobu; Sugimura, Saya; Onuki, Yuichiro; Nakajima, Hiroyuki
• Is Part Of: Clinical case reports. Volume 10:Issue 12(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-12-27
• Subjects: cardiac tamponade -- immunotherapy -- non‐small cell lung cancer -- pembrolizumab -- radiotherapy; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.6795
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: A 69‐year‐old man with non‐small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long‐term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even when complicated by cardiac tamponade. Abstract : Patients with advanced lung cancer who develop cardiac tamponade can be treated with pembrolizumab and achieve long‐term prognosis without any serious adverse events.